找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Chemical Epigenetics; Antonello Mai Book 2020 Springer Nature Switzerland AG 2020 Epigenetic targets.HDAC inhibitors.cyclic peptides.SIRT

[復(fù)制鏈接]
樓主: 獨(dú)裁者
41#
發(fā)表于 2025-3-28 16:57:50 | 只看該作者
42#
發(fā)表于 2025-3-28 20:26:37 | 只看該作者
43#
發(fā)表于 2025-3-29 02:30:07 | 只看該作者
44#
發(fā)表于 2025-3-29 06:16:18 | 只看該作者
Lysine Methyltransferases and Their Inhibitors,ing body of literature is indicating that lysine methyltransferases (KMTs) play a crucial role for transcriptional regulation and are involved in cancer and various other human diseases, thus being of high interest as potential therapeutic targets..In this book chapter, we highlight the discovery, c
45#
發(fā)表于 2025-3-29 09:14:47 | 只看該作者
46#
發(fā)表于 2025-3-29 11:30:01 | 只看該作者
Lysine-Specific Histone Demethylases 1/2 (LSD1/2) and Their Inhibitors,une response, and signal transduction. Histone methylation is closely associated with the oncogenesis and proliferation of cancer cells, and its alteration has been identified in many cancer cells. In addition, histone methylation is involved in such non-cancerous diseases as globin disorders and ne
47#
發(fā)表于 2025-3-29 18:31:13 | 只看該作者
Inhibitors of JmjC-Containing Histone Demethylases,hylation and dysregulation of KDMs have been linked to multiple diseases, and KDMs are emerging as promising therapeutic targets. This chapter provides an overview of JmjC-domain-containing KDMs (JmjC-KDMs), with a particular focus on recent advances in JmjC-KDM inhibitor development from a structur
48#
發(fā)表于 2025-3-29 20:29:09 | 只看該作者
49#
發(fā)表于 2025-3-30 01:38:36 | 只看該作者
50#
發(fā)表于 2025-3-30 06:53:46 | 只看該作者
Methyl-Readers and Inhibitors,mall-molecule intervention. Within this book chapter, the biological role and the associated development of potent small molecules inhibiting the protein-protein interaction of methyllysine readers (Tudor, malignant brain tumor, chromo-, and PHD domain) will be discussed. The druggability of these r
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 22:53
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
云霄县| 五寨县| 龙岩市| 澄迈县| 柳林县| 嵊泗县| 耿马| 南开区| 成武县| 新沂市| 山阳县| 昌江| 凤冈县| 丰城市| 乌兰浩特市| 崇州市| 高密市| 靖宇县| 宜宾县| 宁波市| 健康| 龙门县| 武义县| 固原市| 江都市| 东莞市| 安福县| 宁陕县| 绥芬河市| 体育| 于田县| 两当县| 合水县| 凌云县| 轮台县| 酒泉市| 苗栗市| 徐水县| 肇东市| 吉林省| 宁海县|